Brattea
Latest round
- Series D
Last raised
- Mar 2024
Total raised
- $15M
Investors
- 20
About Brattea
Established in 2013 and based in Shanghai, China, Brattea is a medical equipment company that provides cardiology intervention therapy equipment. It has obtained 14 invention patents and 13 new utility patents, and has passed CE certification. The company's founder and CTO, Hongguang Cao served as a CTO of TCL Medical Group, and chairman of IRAY TECHNOLOGY COMPANY LIMITED. The company mainly provides Netrod ® mesh multi electrode renal artery radiofrequency ablation system (Netrod ® system) for high blood pressure. The Netrod ® system is an RDN (Renal Denervation) product, which supports the catheter inserted into the renal artery vessel and performed radiofrequency ablation on the sympathetic nerve of the renal artery. Brattea also provides EDN (Early Diabetic Nephropathy) treatment method, which can reduce glycosylated hemoglobin and be used to treat type II diabetes.
Who invested in Brattea
20 investors across 6 rounds
See all investors in Brattea
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Mar 25, 2024
Amount
Undisclosed
Investors
Series C
Dec 22, 2022
Amount
Undisclosed
Investors
Series B
Apr 6, 2021
Amount
$15M
Investors
Series B
Jul 16, 2019
Amount
Undisclosed
Investors
Series B
Nov 24, 2016
Amount
Undisclosed
Investors
Angel
Aug 15, 2013
Amount
Undisclosed
Investors
Questions about Brattea
Who invested in Brattea?
Brattea has 20 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Brattea raised?
Brattea has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Brattea last raise money?
Brattea's most recent round on record is a Series D, in Mar 2024.
What does Brattea do?
Established in 2013 and based in Shanghai, China, Brattea is a medical equipment company that provides cardiology intervention therapy equipment.
Where is Brattea headquartered?
Brattea is headquartered in Shanghai, China.
Which VCs invest in companies like Brattea?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Brattea's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Brattea? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.